DK3866833T3 - Sammensætninger, som omfatter rekombinant fsh, til behandling af infertilitet - Google Patents

Sammensætninger, som omfatter rekombinant fsh, til behandling af infertilitet Download PDF

Info

Publication number
DK3866833T3
DK3866833T3 DK19794444.0T DK19794444T DK3866833T3 DK 3866833 T3 DK3866833 T3 DK 3866833T3 DK 19794444 T DK19794444 T DK 19794444T DK 3866833 T3 DK3866833 T3 DK 3866833T3
Authority
DK
Denmark
Prior art keywords
infertility
compositions
treatment
recombinant fsh
fsh
Prior art date
Application number
DK19794444.0T
Other languages
English (en)
Inventor
Saez Joan-Carles Arce
Lisbeth Helmgaard
Bjarke Mirner Klein
Patrick Heiser
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK3866833T3 publication Critical patent/DK3866833T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK19794444.0T 2018-10-17 2019-10-17 Sammensætninger, som omfatter rekombinant fsh, til behandling af infertilitet DK3866833T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746812P 2018-10-17 2018-10-17
EP18203167 2018-10-29
PCT/EP2019/078170 WO2020079127A1 (en) 2018-10-17 2019-10-17 Compositions and methods for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
DK3866833T3 true DK3866833T3 (da) 2025-04-28

Family

ID=68344788

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19794444.0T DK3866833T3 (da) 2018-10-17 2019-10-17 Sammensætninger, som omfatter rekombinant fsh, til behandling af infertilitet

Country Status (30)

Country Link
US (2) US12311012B2 (da)
EP (2) EP3866833B1 (da)
JP (2) JP7555915B2 (da)
KR (1) KR20210079276A (da)
CN (1) CN112789053A (da)
AU (1) AU2019363279B2 (da)
BR (1) BR112021005019A2 (da)
CA (1) CA3110205A1 (da)
CL (2) CL2021000928A1 (da)
CO (1) CO2021005872A2 (da)
DK (1) DK3866833T3 (da)
ES (1) ES3026229T3 (da)
FI (1) FI3866833T3 (da)
HR (1) HRP20250463T1 (da)
HU (1) HUE070973T2 (da)
IL (1) IL280750A (da)
JO (1) JOP20210025B1 (da)
LT (1) LT3866833T (da)
MA (1) MA53909B1 (da)
MD (1) MD3866833T2 (da)
MX (1) MX2021004383A (da)
MY (1) MY210133A (da)
PH (1) PH12021550417A1 (da)
PL (1) PL3866833T3 (da)
RS (1) RS66713B1 (da)
SG (1) SG11202102340RA (da)
SI (1) SI3866833T1 (da)
TW (1) TWI846743B (da)
UA (1) UA128731C2 (da)
WO (1) WO2020079127A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020002235A (es) 2017-09-01 2020-07-20 Ferring Bv Composicion para la estimulacion ovarica controlada.
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002257A (es) * 2001-09-12 2004-07-23 Applied Research Systems Uso de gonadotropina corionica humana (gch) y su hormona de liberacion (hl) en hiperestimulacion ovarica controlada.
EP1364658A1 (en) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
EP2717904A1 (en) 2011-06-06 2014-04-16 Ferring BV Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP2956542A4 (en) 2013-02-15 2016-09-14 Sungkwang Medical Foundation PREPARATION OF PARTHENOGENETIC STEM CELLS AND PATIENT-SPECIFIC HEMAN EMBRYONIC STEM CELLS USING A SOMOCOMOTIVE TRANSFER
EP3283097B1 (en) 2015-04-17 2020-02-12 Ferring B.V. Fsh for treatment of infertility
MX2020002235A (es) 2017-09-01 2020-07-20 Ferring Bv Composicion para la estimulacion ovarica controlada.
HUE071268T2 (hu) 2018-04-30 2025-08-28 Ferring Bv Készítmény szabályozott petefészek-stimuláláshoz
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法

Also Published As

Publication number Publication date
EP4516354A3 (en) 2025-05-14
JP2022505191A (ja) 2022-01-14
CO2021005872A2 (es) 2021-09-20
FI3866833T3 (fi) 2025-05-21
PH12021550417A1 (en) 2021-09-20
TW202027780A (zh) 2020-08-01
HUE070973T2 (hu) 2025-07-28
TWI846743B (zh) 2024-07-01
KR20210079276A (ko) 2021-06-29
US12311012B2 (en) 2025-05-27
MA53909A (fr) 2022-01-26
JP2024133520A (ja) 2024-10-02
RS66713B1 (sr) 2025-05-30
EP4516354A2 (en) 2025-03-05
LT3866833T (lt) 2025-04-25
SG11202102340RA (en) 2021-05-28
JP7555915B2 (ja) 2024-09-25
CN112789053A (zh) 2021-05-11
EP3866833A1 (en) 2021-08-25
CL2022000779A1 (es) 2022-11-25
JOP20210025A1 (ar) 2021-02-07
WO2020079127A1 (en) 2020-04-23
US20210353717A1 (en) 2021-11-18
PL3866833T3 (pl) 2025-06-23
SI3866833T1 (sl) 2025-06-30
BR112021005019A2 (pt) 2021-06-08
CA3110205A1 (en) 2020-04-23
HRP20250463T1 (hr) 2025-06-06
MD3866833T2 (ro) 2025-07-31
AU2019363279B2 (en) 2025-04-03
MX2021004383A (es) 2021-06-04
UA128731C2 (uk) 2024-10-09
MY210133A (en) 2025-08-28
ES3026229T3 (en) 2025-06-10
AU2019363279A1 (en) 2021-03-11
JOP20210025B1 (ar) 2024-12-22
EP3866833B1 (en) 2025-02-19
US20250325637A1 (en) 2025-10-23
IL280750A (en) 2021-04-29
CL2021000928A1 (es) 2021-10-22
MA53909B1 (fr) 2025-07-31

Similar Documents

Publication Publication Date Title
DK3728284T3 (da) 19-homo, 3.alpha.-hydroxy-steroid-20-on forbindelser til behandling af cns-lidelser
DK3501542T3 (da) Esketamin til behandling af depression
DK3856436T3 (da) Fremgangsmåde til opnåelse af omkostningseffektive, geometrisk komplekse emner
DK3341355T3 (da) (s)-3-amino-4-(difluormethylenyl)cyclopent-1-en-1-carboxylsyre og tilhørende forbindelser som gaba-aminotransferaseinaktivatorer til behandling af epilepsi, afhængighed og hepatocellulært karcinom
DK3661514T3 (da) Mavacamten til behandling af hypertrofisk kardiomyopati
DK3524059T3 (da) Køledyse til en ekstruder
DK3658140T3 (da) Kombinationer af aprocitentan med yderligere aktive bestanddele til behandlingen af resistent hypertension
DK3662925T3 (da) Sammensætning, der omfatter fsh, til behandling af infertilitet
DK3460102T3 (da) Fremgangsmåde til fremstilling af en elektrokatalysator
DK4101454T3 (da) Sammensætninger til behandling af hypertension
DK3752283T3 (da) Overlegen kerne-i-skal-komponent-kompositadsorbenter til vsavpsapsa-systemer
EP3849570A4 (en) Blood plasma-containing compositions
EA202191471A1 (ru) Противовоспалительные полипептиды
DK3886799T3 (da) Sammensætninger til behandlingen af hårtab
DK3623321T3 (da) Transportsystem, fremgangsmåde til fremstilling af transportsystemet
IL279942A (en) Terpene-enriched cannabinoid composition for treatment of male subjects
EP4031015A4 (en) FEMORAL ELEMENT EXTRACTOR
DK3638293T3 (da) Sammensætninger til behandling af cancer
DK3613803T3 (da) Sammensætning til silikonegummimasser.
DK3347360T3 (da) Forbindelser, som er anvendelige til inhibering af ror-gamma-t
DK3923914T3 (da) Afabicin-formulering, fremgangsmåde til fremstilling deraf
DK3458467T3 (da) Fremgangsmåde til 6,7-alfa-epoxidering af steroid-4,6-diener
DK3468547T3 (da) Hidtil ukendte benzensulfonamidsammensætninger til behandling af maligne pleuraeffusioner
DK3618845T3 (da) Peptider til behandling af diabetes
DK3397621T3 (da) Fremgangsmåde til fremstilling af 1,1,3-trioxo-1,2-benzothiazol-6-carboxamid